Query 022416
Match_columns 297
No_of_seqs 264 out of 1382
Neff 6.9
Searched_HMMs 46136
Date Fri Mar 29 03:22:21 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/022416.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/022416hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 PLN02615 arginase 100.0 1.1E-54 2.4E-59 411.5 19.7 263 3-265 2-272 (338)
2 KOG2964 Arginase family protei 100.0 2E-53 4.2E-58 384.8 14.1 271 1-281 8-322 (361)
3 COG0010 SpeB Arginase/agmatina 100.0 3.2E-42 6.9E-47 322.8 18.7 233 33-295 2-239 (305)
4 PRK13775 formimidoylglutamase; 100.0 1.2E-40 2.7E-45 315.0 18.8 224 33-295 25-262 (328)
5 TIGR01230 agmatinase agmatinas 100.0 4E-40 8.8E-45 304.5 20.4 195 59-265 12-211 (275)
6 TIGR01227 hutG formimidoylglut 100.0 5.5E-40 1.2E-44 308.0 19.3 203 59-293 34-245 (307)
7 PRK13772 formimidoylglutamase; 100.0 1.2E-39 2.6E-44 306.5 19.0 202 59-295 40-255 (314)
8 PRK13774 formimidoylglutamase; 100.0 1.4E-39 2.9E-44 305.9 18.4 202 59-294 43-250 (311)
9 PRK02190 agmatinase; Provision 100.0 1.8E-39 3.9E-44 303.8 18.9 215 31-265 4-231 (301)
10 PRK01722 formimidoylglutamase; 100.0 2.1E-39 4.6E-44 305.7 18.2 200 59-290 40-249 (320)
11 PRK13776 formimidoylglutamase; 100.0 3.1E-39 6.7E-44 304.3 18.5 202 59-295 41-256 (318)
12 PRK13773 formimidoylglutamase; 100.0 3.6E-39 7.9E-44 304.5 18.8 202 59-295 43-257 (324)
13 PF00491 Arginase: Arginase fa 100.0 6.5E-39 1.4E-43 296.1 16.1 178 60-246 1-182 (277)
14 TIGR01229 rocF_arginase argina 100.0 8.4E-38 1.8E-42 292.4 15.6 205 63-295 1-234 (300)
15 KOG2965 Arginase [Amino acid t 100.0 4.4E-31 9.6E-36 236.3 14.7 192 61-266 16-247 (318)
16 PF12640 UPF0489: UPF0489 doma 94.5 0.16 3.4E-06 43.2 7.4 35 157-191 6-42 (162)
17 KOG1384 tRNA delta(2)-isopente 57.4 20 0.00043 34.4 5.0 58 128-186 77-149 (348)
18 PF01715 IPPT: IPP transferase 37.8 47 0.001 30.4 4.2 38 127-165 36-73 (253)
19 TIGR00287 cas1 CRISPR-associat 33.6 46 0.001 31.4 3.5 34 151-187 37-70 (323)
20 PRK02240 GTP cyclohydrolase II 33.5 99 0.0021 28.6 5.5 52 111-162 9-60 (254)
21 PF00491 Arginase: Arginase fa 30.9 31 0.00068 31.5 1.9 15 251-265 199-213 (277)
22 cd06285 PBP1_LacI_like_7 Ligan 30.2 1.1E+02 0.0023 26.9 5.2 52 137-188 163-217 (265)
23 TIGR03638 cas1_ECOLI CRISPR-as 27.0 74 0.0016 29.4 3.6 33 150-185 46-78 (269)
24 TIGR03641 cas1_HMARI CRISPR-as 25.9 72 0.0016 30.3 3.4 33 151-186 36-68 (322)
25 COG0324 MiaA tRNA delta(2)-iso 25.9 88 0.0019 29.7 3.9 41 127-168 72-112 (308)
26 PF01867 Cas_Cas1: CRISPR asso 23.8 80 0.0017 29.1 3.2 33 151-186 37-69 (282)
27 TIGR03640 cas1_DVULG CRISPR-as 22.4 96 0.0021 29.6 3.5 33 151-186 41-73 (340)
28 PRK01722 formimidoylglutamase; 21.7 49 0.0011 31.2 1.4 14 252-265 238-251 (320)
29 PRK06849 hypothetical protein; 20.9 1.3E+02 0.0028 28.9 4.2 35 149-186 5-39 (389)
30 cd06281 PBP1_LacI_like_5 Ligan 20.1 2.4E+02 0.0052 24.7 5.5 48 135-182 162-212 (269)
No 1
>PLN02615 arginase
Probab=100.00 E-value=1.1e-54 Score=411.55 Aligned_cols=263 Identities=85% Similarity=1.299 Sum_probs=227.0
Q ss_pred ccccccccchhhhhcccCCChHHHhhccccccccchhhhhhhhhhhhHHHhhhcCCcCcEEEEEeecCCCCCCCCCccch
Q 022416 3 AMIGKRGVHYLQKLKSANIPIAVIEKGQNRVIDASLTLIRERAKLKGELVRALGGAVASTSLLGVPLGHNSSFLQGPAFA 82 (297)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~tf~~~~~~~~~~~~~~l~~~~~~i~llGvP~D~g~s~r~Ga~~G 82 (297)
.++|+||+|||||+++++++.+.++..+++.|++..||+++|..||.+++++.++.+++++|+|+|||.+++||+|+|+|
T Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~ilGvP~D~~~s~r~G~r~g 81 (338)
T PLN02615 2 VAIGRRGIHYLQRLIAASVPASLLEKGQNRVIDASLTLIRERAKLKGELVRALGGAKASSCLLGVPLGHNSSFLQGPAFA 81 (338)
T ss_pred chHHHHHHHHHHHHHHHhccHHHhhcCCCcccccchhhccCcccccccccCCcccCCCCEEEEeCCCCCCCCCCCchhhh
Confidence 36899999999999999999999999999999999999999988999988887766779999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCcccCCCCCCCccccccCCcccccccCCCCCHHHHHHHHHHHHHHHHhcCCceeEEeCCCCcchH
Q 022416 83 PPRIREAIWCGSTNSTTEEGKELNDPRVLTDVGDVPVQEIRDCGVDDDRLMNVITESVKLVMEEDPLHPLVLGGDHSISF 162 (297)
Q Consensus 83 P~aIR~a~~~~~~~~~~~~g~~~~~~~~i~D~GDv~~~~~~~~~~~~~~~~~~l~~~v~~vl~~g~~~pIvLGGDHsit~ 162 (297)
|++||++++...++...+.+.++.+...++|+||+++.+.+..+.+.+++++++++.++.++++++.+||+||||||+||
T Consensus 82 P~aIR~as~~~~~~~~~~~~~~~~~~~~i~D~GDv~v~~~~~~g~~~~~~~~~i~~~v~~ll~~~~~~Pi~LGGDHsit~ 161 (338)
T PLN02615 82 PPRIREAIWCGSTNSTTEEGKELNDPRVLTDVGDVPVQEIRDCGVDDDRLMNVISESVKLVMEEEPLRPLVLGGDHSISY 161 (338)
T ss_pred HHHHHHHHhcCccCCccccCCChhhcCeeEecCCCcCCcccccccCHHHHHHHHHHHHHHHHhcCCCceEEECcchHhhH
Confidence 99999999755444434446666555448999999986532222267999999999999999864358999999999999
Q ss_pred HhHHHHHHHcCCCeEEEEEecCCCCCCCCCCCccCCchHHHHHHcCCCCCcEEEEeeCCCCHHHHHHHHHcCCeEEEccc
Q 022416 163 PVIRAVSEKLGGPVDVLHLDAHPDIYDAFEGNKYSHASSFARIMEGGYARRLLQVGIRSITKEGREQGKRFGVEQYEMRT 242 (297)
Q Consensus 163 ~~i~al~~~~~~~i~VI~fDAH~Dl~~~~~G~~~shGt~~~~~~e~g~~~~iv~iGiR~~~~~e~~~~~~~gv~~~~~~d 242 (297)
|.++|+.++++++++|||||||+|+++++.|+.++|||||++++|.+..++++|||+|+++++|+++++++|+.++++++
T Consensus 162 ~~iral~~~~~~~v~vI~fDAH~Dl~~~~~g~~~shgs~~rr~~e~~~~~~~vqiGiR~~~~~e~~~~~~~g~~~~~~~~ 241 (338)
T PLN02615 162 PVVRAVSEKLGGPVDILHLDAHPDIYHAFEGNKYSHASSFARIMEGGYARRLLQVGIRSITKEGREQGKRFGVEQYEMRT 241 (338)
T ss_pred HHHHHHHHHhCCCeEEEEEecCcCCCCCCCCCCcCchhHHHHHhhCCCcCcEEEEeecCCCHHHHHHHHHCCCEEEEeeH
Confidence 99999998886689999999999999999999999999999999987778999999999999999999999999999988
Q ss_pred ccccc----cc----cccceEEEEecchhcc
Q 022416 243 FSRDR----QF----LENLVSLSLLLKYIHI 265 (297)
Q Consensus 243 i~~~~----~~----~~~~v~is~D~d~~~~ 265 (297)
+.+.. .+ ..+++|||+|+|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~vYiS~DiDvlDp 272 (338)
T PLN02615 242 FSKDREKLENLKLGEGVKGVYISIDVDCLDP 272 (338)
T ss_pred hhhHHHHHHHHHhccCCCeEEEEEeeCccCH
Confidence 86421 11 2256888888888875
No 2
>KOG2964 consensus Arginase family protein [Amino acid transport and metabolism]
Probab=100.00 E-value=2e-53 Score=384.83 Aligned_cols=271 Identities=33% Similarity=0.508 Sum_probs=227.8
Q ss_pred CcccccccccchhhhhcccC-----CChHHHhhccccc----cccchhhhhhhhhhhhHHHhhhcCCcCcEEEEEeecCC
Q 022416 1 MSAMIGKRGVHYLQKLKSAN-----IPIAVIEKGQNRV----IDASLTLIRERAKLKGELVRALGGAVASTSLLGVPLGH 71 (297)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~tf~~~~~~~~~~~~~~l~~~~~~i~llGvP~D~ 71 (297)
||-.+|..|+.|.+++..+. +|...+++.++|. |+|+.||+|||+- +++...+.+.++++||+|||+
T Consensus 8 ~~~~~G~~g~~~~~~l~~~rt~~~~~~d~~~e~~~~~~~da~~sgI~t~~rLp~~----~v~~~~~e~~d~AfiGvPldt 83 (361)
T KOG2964|consen 8 LSRGIGGLGARYAHRLEPARTQSRAVSDDSREQDQSREFDASYSGIATFARLPGV----LVLLSGSEDFDIAFIGVPLDT 83 (361)
T ss_pred hhhcccccccchhhhhccccccccccCcccccCCCCceeehhhhhhHHhhcCCce----EEEecCCCccceEEeccccCC
Confidence 46678899999998877654 6778888888886 6788899999982 244345778899999999999
Q ss_pred CCCCCCCccchHHHHHHHHhcCCCCCCcccCCCCCCCccccccCCcccccccCCCCCHHHHHHHHHHHHHHHH------h
Q 022416 72 NSSFLQGPAFAPPRIREAIWCGSTNSTTEEGKELNDPRVLTDVGDVPVQEIRDCGVDDDRLMNVITESVKLVM------E 145 (297)
Q Consensus 72 g~s~r~Ga~~GP~aIR~a~~~~~~~~~~~~g~~~~~~~~i~D~GDv~~~~~~~~~~~~~~~~~~l~~~v~~vl------~ 145 (297)
|+|+|||+||||..||++++++.++..++.+.++.+|++++|||||+++.+++ ..+.+++.+++-.++ +
T Consensus 84 gtS~rpGarFgP~~IRE~s~~~~t~n~s~e~~pfksw~~l~D~GDIpV~~yd~-----~~a~~q~~~~y~~l~~rkg~a~ 158 (361)
T KOG2964|consen 84 GTSYRPGARFGPSRIREASRRLNTVNPSLEGNPFKSWAKLVDCGDIPVTSYDN-----QGADDQIEEAYISLLARKGVAK 158 (361)
T ss_pred CccCCCccccCCchhhhhhhhhcccCCCcCCccccChhhhcccCCcchhhhhh-----hhHHHHHHHHHHHHHHhhhhcc
Confidence 99999999999999999999998766666677788899999999999998654 344444444444333 3
Q ss_pred cCCceeEEeCCCCcchHHhHHHHHHHcCCCeEEEEEecCCCCCCCCCCCccCCchHHHHHHcCCCCCc--EEEEeeCCCC
Q 022416 146 EDPLHPLVLGGDHSISFPVIRAVSEKLGGPVDVLHLDAHPDIYDAFEGNKYSHASSFARIMEGGYARR--LLQVGIRSIT 223 (297)
Q Consensus 146 ~g~~~pIvLGGDHsit~~~i~al~~~~~~~i~VI~fDAH~Dl~~~~~G~~~shGt~~~~~~e~g~~~~--iv~iGiR~~~ 223 (297)
.++.+|++|||||||+||.+||+.++|+ +++|||||||+|+|++.+|+.+|||++|++++++|+..+ .+|+|||+..
T Consensus 159 ~~~~~PltLGGDHtI~yPilRAvs~k~G-PV~ilH~DaH~Dt~d~~~g~~~~Hgs~F~r~~~eGl~~~~~~iq~GIRt~~ 237 (361)
T KOG2964|consen 159 DGPVLPLTLGGDHTIVYPILRAVSRKYG-PVSILHFDAHLDTWDPKEGGKINHGSYFYRASQEGLASNDRNIQAGIRTIL 237 (361)
T ss_pred CCceeeeeecCCceeeHHHHHHHHHhhC-CceEEEeccCccccCccccCccccchHHHHHhhcccccCCceeeeeeeecc
Confidence 4556799999999999999999999995 999999999999999999999999999999999998765 9999999975
Q ss_pred HH--HHHHHHHcCCeEEEcccccccc----------cccccceEEEEecchhccc---------------hhhhHHHHhh
Q 022416 224 KE--GREQGKRFGVEQYEMRTFSRDR----------QFLENLVSLSLLLKYIHIL---------------SQLQTVIRAY 276 (297)
Q Consensus 224 ~~--e~~~~~~~gv~~~~~~di~~~~----------~~~~~~v~is~D~d~~~~~---------------~~~~~~~~~~ 276 (297)
.+ .++.-+++|++++.|++|++.+ ...++++|||+|+|++++. +++..+|+.+
T Consensus 238 s~~~~ye~d~~~Gf~~ieare~~~~gi~~i~e~ir~~~G~k~vYiSiDID~LDPafAPgtgtpE~gGlt~re~l~ILrgl 317 (361)
T KOG2964|consen 238 SGLSDYEQDKRCGFEIIEAREIDKIGIDPIVERIRQRVGDKLVYISIDIDVLDPAFAPGTGTPETGGLTTREMLNILRGL 317 (361)
T ss_pred cCcCchhhccccCeEEEEeeehhhhhhHHHHHHHHHhcCCceEEEEEeecccCcccCCCCCCCCCCCcCHHHHHHHHhhC
Confidence 55 7888899999999999999863 4688999999999999984 4677788888
Q ss_pred chhhc
Q 022416 277 IAFFY 281 (297)
Q Consensus 277 ~~~~~ 281 (297)
+.+-+
T Consensus 318 qGl~l 322 (361)
T KOG2964|consen 318 QGLNL 322 (361)
T ss_pred ccccc
Confidence 87554
No 3
>COG0010 SpeB Arginase/agmatinase/formimionoglutamate hydrolase, arginase family [Amino acid transport and metabolism]
Probab=100.00 E-value=3.2e-42 Score=322.84 Aligned_cols=233 Identities=27% Similarity=0.432 Sum_probs=189.5
Q ss_pred ccccchhhhhhhhhhhhHHHhhhcCCcCcEEEEEeecCCCCCCCCCccchHHHHHHHHhcCCCCCCcccCCCCCCCcccc
Q 022416 33 VIDASLTLIRERAKLKGELVRALGGAVASTSLLGVPLGHNSSFLQGPAFAPPRIREAIWCGSTNSTTEEGKELNDPRVLT 112 (297)
Q Consensus 33 ~~~~~~tf~~~~~~~~~~~~~~l~~~~~~i~llGvP~D~g~s~r~Ga~~GP~aIR~a~~~~~~~~~~~~g~~~~~~~~i~ 112 (297)
.++++.||+++++.++ ... ..+++|+|+|+|.|+++|+|+++||++||+++....++ .....++....+++
T Consensus 2 ~~~~~~~~~~~~~~~~------~~~-~~~~~i~g~p~d~~~s~r~Ga~~GP~air~a~~~~~~~--~~~~~~~~~~~~~~ 72 (305)
T COG0010 2 RLSGIFTFLRLPDSLN------GYE-DADIAIIGVPFDGGTSYRPGARFGPDAIREASLNLEYN--VPLDGDLVEALKIA 72 (305)
T ss_pred CcccccchhccccccC------chh-cCceEEEeeccccCcCCCcchhhCHHHHHHHhhhcccC--cccccCcccccCcc
Confidence 3678899999998432 222 56999999999999999999999999999999876511 11122222212589
Q ss_pred ccCCcccccccCCCCCHHHHHHHHHHHHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHcCCCeEEEEEecCCCCCCCCC
Q 022416 113 DVGDVPVQEIRDCGVDDDRLMNVITESVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKLGGPVDVLHLDAHPDIYDAFE 192 (297)
Q Consensus 113 D~GDv~~~~~~~~~~~~~~~~~~l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~~~~i~VI~fDAH~Dl~~~~~ 192 (297)
|+||+.... .+.+..++++++++.+++.++ .+||+||||||||+|+++|++++++.+++|||||||+|+|++++
T Consensus 73 d~gd~~~~~-----~~~~~~~~~~~~~~~~~~~~~-~~pi~lGGDHsit~~~~~a~~~~~~~~~gvI~iDAH~Dl~~~~~ 146 (305)
T COG0010 73 DLGDIELNG-----GDLEDAVDAIEEAVAELLSAG-AFPIVLGGDHSITLGTVRALARKYGGPLGVIWIDAHADLRTPYS 146 (305)
T ss_pred CCCCccCCc-----ccHHHHHHHHHHHHHHHHhcC-CeeEEECCcchhhHHHHHHHHHhhCCceEEEEEecCccCCCCCC
Confidence 999998875 256899999999999999998 69999999999999999999998754799999999999999988
Q ss_pred CCccCCchHHHHHHcCCC----CCcEEEEeeCCCCHHH-HHHHHHcCCeEEEcccccccccccccceEEEEecchhccch
Q 022416 193 GNKYSHASSFARIMEGGY----ARRLLQVGIRSITKEG-REQGKRFGVEQYEMRTFSRDRQFLENLVSLSLLLKYIHILS 267 (297)
Q Consensus 193 G~~~shGt~~~~~~e~g~----~~~iv~iGiR~~~~~e-~~~~~~~gv~~~~~~di~~~~~~~~~~v~is~D~d~~~~~~ 267 (297)
|+.++|||||++++|++. +++++|+|+|+.+++| .+.++++|+++++|+++++.. ..-.+..
T Consensus 147 g~~~~Hg~p~r~~~e~~~~~~~p~~~v~iGiR~~~~~e~~~~~~~~gi~~~~~~~v~~~~-------------~~~~~~~ 213 (305)
T COG0010 147 GSGNSHGTPLRRALEEGLIDGGPENVVQIGIRSVDPEERAAVARERGIRVLTARDVDELG-------------LVDVIEE 213 (305)
T ss_pred CCCCcccCHHHHHHhccccCCCcceEEEEEeccCChHHHHHHHHhcCCEEEEHHHHHHhc-------------CHHHHHH
Confidence 999999999999999864 3789999999998888 568899999999999998731 1113355
Q ss_pred hhhHHHHhhchhhccccccccccccccc
Q 022416 268 QLQTVIRAYIAFFYLLCLTFDVFIQTTA 295 (297)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 295 (297)
.+.++....|.+|+| ||+|||..+.|
T Consensus 214 ~i~~~~~~~~~vylS--iDiD~lDPa~a 239 (305)
T COG0010 214 AIDELKGDGDPVYLS--IDLDVLDPAFA 239 (305)
T ss_pred HHHHhhCCCCeEEEE--EecCCcCcccC
Confidence 566666667778999 99999877654
No 4
>PRK13775 formimidoylglutamase; Provisional
Probab=100.00 E-value=1.2e-40 Score=315.00 Aligned_cols=224 Identities=16% Similarity=0.269 Sum_probs=178.4
Q ss_pred ccccchhhhhhh--hhhhhHHHhhhcCCcCcEEEEEeecCCCC---CCCCCccchHHHHHHHHhcCCCCCCcccCCCCCC
Q 022416 33 VIDASLTLIRER--AKLKGELVRALGGAVASTSLLGVPLGHNS---SFLQGPAFAPPRIREAIWCGSTNSTTEEGKELND 107 (297)
Q Consensus 33 ~~~~~~tf~~~~--~~~~~~~~~~l~~~~~~i~llGvP~D~g~---s~r~Ga~~GP~aIR~a~~~~~~~~~~~~g~~~~~ 107 (297)
.+.++.||+++| + .+++++ ++++|||+|||.|+ ++|+|+++||++||+++..+.++. +. +
T Consensus 25 ~~~~~~~~~~~~~~~------~~~~~~--~~v~iiGvP~d~g~~~n~~r~Ga~~gP~aIR~~l~~~~~~~----~~---~ 89 (328)
T PRK13775 25 KWGMVMTFLDLNDSS------LTPFEG--THFALIGFKSDKGVYINNGRVGAVESPAAIRTQLAKFPWHL----GN---Q 89 (328)
T ss_pred eeeeccchhcccccc------cccccC--CCEEEEEeccccccCCCCCCcChhHhHHHHHHHHhcccccc----CC---C
Confidence 567888999986 5 233433 59999999999998 689999999999999986543211 11 1
Q ss_pred CccccccCCcccccccCCCCCHHHHHHHHHHHHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHcC--CCeEEEEEecCC
Q 022416 108 PRVLTDVGDVPVQEIRDCGVDDDRLMNVITESVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKLG--GPVDVLHLDAHP 185 (297)
Q Consensus 108 ~~~i~D~GDv~~~~~~~~~~~~~~~~~~l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~~--~~i~VI~fDAH~ 185 (297)
..++|+|||++.. .+.+++++++++.|+++++++ ++||+||||||+|+|+++|++++++ ++++|||||||+
T Consensus 90 -~~i~D~Gdv~~~~-----~~~~~~~~~l~~~v~~~~~~g-~~PivlGGdHsit~g~~~g~~~~~~~~~~~gvI~~DAH~ 162 (328)
T PRK13775 90 -VMVYDVGNIDGPN-----RSLEQLQNSLSKAIKRMCDLN-LKPIVLGGGHETAYGHYLGLRQSLSPSDDLAVINMDAHF 162 (328)
T ss_pred -CEEEeCCCcCCCC-----cCHHHHHHHHHHHHHHHHhCC-CeEEEEcCcHHHHHHHHHHHHHhcccCCCeEEEEeccCc
Confidence 3589999998764 357899999999999999998 6999999999999999999999762 589999999999
Q ss_pred CCCCCCCCCccCCchHHHHHHcCCC----CCcEEEEeeCCCC--HHHHHH-HHHcCCeEEEcccccccccccccceEEEE
Q 022416 186 DIYDAFEGNKYSHASSFARIMEGGY----ARRLLQVGIRSIT--KEGREQ-GKRFGVEQYEMRTFSRDRQFLENLVSLSL 258 (297)
Q Consensus 186 Dl~~~~~G~~~shGt~~~~~~e~g~----~~~iv~iGiR~~~--~~e~~~-~~~~gv~~~~~~di~~~~~~~~~~v~is~ 258 (297)
|+|+ +.++.++|||+|+++++++. .++++|+|+|+.. ++++++ .++.|+.++++.++++.
T Consensus 163 Dlr~-~~~~~~shg~~~~~~~~~~~~~~~~~~~~~iGiR~~~~~~~~~~~~~~~~gi~~~~~~~i~~~------------ 229 (328)
T PRK13775 163 DLRP-YDQTGPNSGTGFRQMFDDAVADKRLFKYFVLGIQEHNNNLFLFDFVAKSKGIQFLTGQDIYQM------------ 229 (328)
T ss_pred CCCC-CCCCCCCCCcHHHHHHHhhcccCCCceEEEEEEeCCCCCHHHHHHHHHHcCCEEEEHHHhhhc------------
Confidence 9996 55667899999999987532 3479999999963 467886 45689999999999764
Q ss_pred ecchhccchhhhHHHHhhchhhccccccccccccccc
Q 022416 259 LLKYIHILSQLQTVIRAYIAFFYLLCLTFDVFIQTTA 295 (297)
Q Consensus 259 D~d~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 295 (297)
..-.+..++.++++..|.+|+| ||+|||-.+.|
T Consensus 230 --g~~~v~~~~~~~~~~~~~vyvS--~DiD~lDps~a 262 (328)
T PRK13775 230 --GHQKVCRAIDRFLEGQERVYLT--IDMDCFSVGAA 262 (328)
T ss_pred --CHHHHHHHHHHHHhcCCeEEEE--EEcCccCcccC
Confidence 2223445666666667788888 88888876654
No 5
>TIGR01230 agmatinase agmatinase. Note: a history of early misannotation of members of this family is detailed in PUBMED:10931887.
Probab=100.00 E-value=4e-40 Score=304.52 Aligned_cols=195 Identities=30% Similarity=0.498 Sum_probs=165.0
Q ss_pred cCcEEEEEeecCCCCCCCCCccchHHHHHHHHhcCCCCCCcccCCCCCCCccccccCCcccccccCCCCCHHHHHHHHHH
Q 022416 59 VASTSLLGVPLGHNSSFLQGPAFAPPRIREAIWCGSTNSTTEEGKELNDPRVLTDVGDVPVQEIRDCGVDDDRLMNVITE 138 (297)
Q Consensus 59 ~~~i~llGvP~D~g~s~r~Ga~~GP~aIR~a~~~~~~~~~~~~g~~~~~~~~i~D~GDv~~~~~~~~~~~~~~~~~~l~~ 138 (297)
+++++|+|+|+|.|+++|+|+++||++||+++..+..+. .+.+.++.. ..++|+||+.+.. .+.+++++++++
T Consensus 12 ~~~v~viGvP~d~g~~~~~G~~~gP~aiR~a~~~~~~~~-~~~~~~~~~-~~i~D~Gdv~~~~-----~~~~~~~~~i~~ 84 (275)
T TIGR01230 12 EADWVIYGIPYDATTSYRPGSRHGPNAIREASWNLEWYS-NRLDRDLAM-LNVVDAGDLPLAF-----GDAREMFEKIQE 84 (275)
T ss_pred CCCEEEECCCCCCCCCCCCchhhhHHHHHHHHhcccccC-cccCCCccc-ceEeecCCCCCCC-----CCHHHHHHHHHH
Confidence 459999999999999999999999999999997765432 233444433 4589999998743 357899999999
Q ss_pred HHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHcCCCeEEEEEecCCCCCCCCCCCccCCchHHHHHHcCCCCCcEEEEe
Q 022416 139 SVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKLGGPVDVLHLDAHPDIYDAFEGNKYSHASSFARIMEGGYARRLLQVG 218 (297)
Q Consensus 139 ~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~~~~i~VI~fDAH~Dl~~~~~G~~~shGt~~~~~~e~g~~~~iv~iG 218 (297)
++.++++++ .+||+||||||+|+|+++|+.+++ ++++|||||||+|+++++.|+.++||||++++++.+ .+++|+|
T Consensus 85 ~v~~~~~~~-~~pi~lGGdHsis~~~i~al~~~~-~~~~vI~~DAH~D~~~~~~g~~~~~~~~~~~~~~~~--~~iv~iG 160 (275)
T TIGR01230 85 HAEEFLEEG-KFPVAIGGEHSITLPVIRAMAKKF-GKFAVVHFDAHTDLRDEFDGGTLNHACPMRRVIELG--LNVVQFG 160 (275)
T ss_pred HHHHHHhcC-CeEEEecCcchhhHHHHHHHHHhc-CCeEEEEEecccccccccCCCccccHhHHHHHhhCC--CCEEEEE
Confidence 999999988 699999999999999999999987 589999999999999988888889999999999864 5999999
Q ss_pred eCCCCHHHHHHHHHcCCeEEEcccccccc-----cccccceEEEEecchhcc
Q 022416 219 IRSITKEGREQGKRFGVEQYEMRTFSRDR-----QFLENLVSLSLLLKYIHI 265 (297)
Q Consensus 219 iR~~~~~e~~~~~~~gv~~~~~~di~~~~-----~~~~~~v~is~D~d~~~~ 265 (297)
+|+++++|+++++++|+.+++ .++.+.. ...+.++|||+|+|++++
T Consensus 161 iR~~~~~e~~~~~~~~~~~~~-~~i~~~~~~~l~~~~~~~vyis~DiDvlDp 211 (275)
T TIGR01230 161 IRSGFKEENDFARENNIQVLK-REVDDVIAEVKQKVGDKPVYVTIDIDVLDP 211 (275)
T ss_pred eCCCChHHHHHHHHcCCEEEe-hHHHHHHHHHHHHhCCCceEEEEeccccCc
Confidence 999999999999999999999 7765421 123456888888888866
No 6
>TIGR01227 hutG formimidoylglutamase. Formiminoglutamase, the fourth enzyme of histidine degradation, is similar to arginases and agmatinases. It is often encoded near other enzymes of the histidine degredation pathway: histidine ammonia-lyase, urocanate hydratase, and imidazolonepropionase.
Probab=100.00 E-value=5.5e-40 Score=308.04 Aligned_cols=203 Identities=21% Similarity=0.331 Sum_probs=167.5
Q ss_pred cCcEEEEEeecCCCCC---CCCCccchHHHHHHHHhcCCCCCCcccCCCCCCCccccccCCcccccccCCCCCHHHHHHH
Q 022416 59 VASTSLLGVPLGHNSS---FLQGPAFAPPRIREAIWCGSTNSTTEEGKELNDPRVLTDVGDVPVQEIRDCGVDDDRLMNV 135 (297)
Q Consensus 59 ~~~i~llGvP~D~g~s---~r~Ga~~GP~aIR~a~~~~~~~~~~~~g~~~~~~~~i~D~GDv~~~~~~~~~~~~~~~~~~ 135 (297)
+++++|||+|+|.|++ +|+|+++||++||+++..+..+ . .+ ..++|+|||.+.. .+.++++++
T Consensus 34 ~~~i~iiGvP~d~g~~~n~~r~G~~~gP~aiR~a~~~~~~~-----~---~~-~~i~D~Gdv~~~~-----~~~~~~~~~ 99 (307)
T TIGR01227 34 EKGVALIGFPLDKGVIRNKGRRGARHGPSAIRQALAHLGDW-----H---VS-ELLYDLGDIVIHG-----DDLEDTQHE 99 (307)
T ss_pred CCCEEEEeeccCccccCCCCCcChhHCHHHHHHHHHhcccc-----C---CC-CEEEeCCCCccCc-----hhHHHHHHH
Confidence 4599999999999998 9999999999999999765311 1 11 3589999998754 357999999
Q ss_pred HHHHHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHcCC-C-eEEEEEecCCCCCCCCCCCccCCchHHHHHHcCCC--C
Q 022416 136 ITESVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKLGG-P-VDVLHLDAHPDIYDAFEGNKYSHASSFARIMEGGY--A 211 (297)
Q Consensus 136 l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~~~-~-i~VI~fDAH~Dl~~~~~G~~~shGt~~~~~~e~g~--~ 211 (297)
+++.++++++++ .+||+||||||+|+|+++|+++++++ + ++|||||||+|+++++. +.++|||||+++++++. .
T Consensus 100 i~~~v~~~~~~g-~~Pi~lGGdHsit~~~~~al~~~~~~~~~vgvi~~DAH~D~~~~~~-~~~~~g~~~~~~~~~~~~~~ 177 (307)
T TIGR01227 100 IAQTAAALLADH-RVPVILGGGHSIAYATFAALAQHYKGTTAIGVINFDAHFDLRATED-GGPTSGTPFRQILDECQIED 177 (307)
T ss_pred HHHHHHHHHhcC-CeEEEECCcchhHHHHHHHHHHhcCCCCeEEEEEEccCcCCCCCCC-CCCCCchHHHHHhhccCCCC
Confidence 999999999999 69999999999999999999998743 4 99999999999999863 45889999999999764 4
Q ss_pred CcEEEEeeCCC--CHHHHHHHHHcCCeEEEcccccccccccccceEEEEecchhccchhhhHHHHhhchhhccccccccc
Q 022416 212 RRLLQVGIRSI--TKEGREQGKRFGVEQYEMRTFSRDRQFLENLVSLSLLLKYIHILSQLQTVIRAYIAFFYLLCLTFDV 289 (297)
Q Consensus 212 ~~iv~iGiR~~--~~~e~~~~~~~gv~~~~~~di~~~~~~~~~~v~is~D~d~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 289 (297)
++++|+|+|++ +++++++++++|+.++++.+++.. ..-.+...+..++...|.+|+| ||+||
T Consensus 178 ~~~~~iGiR~~~~~~~~~~~~~~~g~~~~~~~~i~~~--------------~~~~i~~~~~~~~~~~~~vyvs--~DiDv 241 (307)
T TIGR01227 178 FHYAVLGIRRFSNTQALFDYAKKLGVRYVTDDALRPG--------------LLPTIKDILPVFLDKVDHIYLT--VDMDV 241 (307)
T ss_pred CcEEEEEecCCCCCHHHHHHHHHCCCEEEEHHHhhhc--------------CHHHHHHHHHHHHhCCCeEEEE--EEecc
Confidence 68999999997 568899999999999999998652 1113345555556667778888 88888
Q ss_pred cccc
Q 022416 290 FIQT 293 (297)
Q Consensus 290 ~~~~ 293 (297)
|-.+
T Consensus 242 lDps 245 (307)
T TIGR01227 242 LDAA 245 (307)
T ss_pred cChh
Confidence 7443
No 7
>PRK13772 formimidoylglutamase; Provisional
Probab=100.00 E-value=1.2e-39 Score=306.53 Aligned_cols=202 Identities=25% Similarity=0.346 Sum_probs=167.0
Q ss_pred cCcEEEEEeecCCCC---CCCCCccchHHHHHHHHhcCCCCCCcccCCCCCCCccccccCCcccccccCCCCCHHHHHHH
Q 022416 59 VASTSLLGVPLGHNS---SFLQGPAFAPPRIREAIWCGSTNSTTEEGKELNDPRVLTDVGDVPVQEIRDCGVDDDRLMNV 135 (297)
Q Consensus 59 ~~~i~llGvP~D~g~---s~r~Ga~~GP~aIR~a~~~~~~~~~~~~g~~~~~~~~i~D~GDv~~~~~~~~~~~~~~~~~~ 135 (297)
+++++|+|+|||.|+ ++|+|+++||++||+++.++..+ + ...++|+|||++.. .+.++++++
T Consensus 40 ~~~~~ilGvP~D~g~~~n~~r~Gar~gP~aIR~as~~l~~~-----~-----~~~i~D~Gdv~~~~-----~~~~~~~~~ 104 (314)
T PRK13772 40 AGAPVLLGFACDAGVRRNQGRAGAAHGPREIRRALAGVPAH-----G-----LPALADAGDVVCDD-----GDLESAQAA 104 (314)
T ss_pred CCCEEEEEeecCcccCcCCCCchHhHhHHHHHHHHhcCCcC-----C-----CCeEEECCCCCcCC-----cCHHHHHHH
Confidence 569999999999999 89999999999999999775422 1 13589999998754 357999999
Q ss_pred HHHHHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHcC-----CCeEEEEEecCCCCCCCCCCCccCCchHHHHHHcC--
Q 022416 136 ITESVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKLG-----GPVDVLHLDAHPDIYDAFEGNKYSHASSFARIMEG-- 208 (297)
Q Consensus 136 l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~~-----~~i~VI~fDAH~Dl~~~~~G~~~shGt~~~~~~e~-- 208 (297)
+++.+++++++| ++||+||||||+|+|+++|+++..+ ++++|||||||+|++++. .++|||||++++++
T Consensus 105 i~~~v~~~~~~g-~~PivlGGdHsit~g~~~a~~~~~~~~~~~~~~gvI~~DAH~D~r~~~---~~~~Gs~~rri~e~~~ 180 (314)
T PRK13772 105 LAEVVAEVLAAG-ARPLVLGGGHEVAWGTWQGLRAHLDAQGDRGRVLIINLDAHFDLRTSR---PASSGTPFDQIAEDCA 180 (314)
T ss_pred HHHHHHHHHHCC-CEEEEEcCchHHHHhhHHHHHHHhhhcccCCceEEEEecccccCCCCC---CCCCCCHHHHHHHHHH
Confidence 999999999999 6999999999999999999987431 489999999999999864 37899999999984
Q ss_pred --CCCCcEEEEeeCCC--CHHHHHHHHHcCCeEEEcccccccccccccceEEEEecchhccchhhhHHHHhhchhhcccc
Q 022416 209 --GYARRLLQVGIRSI--TKEGREQGKRFGVEQYEMRTFSRDRQFLENLVSLSLLLKYIHILSQLQTVIRAYIAFFYLLC 284 (297)
Q Consensus 209 --g~~~~iv~iGiR~~--~~~e~~~~~~~gv~~~~~~di~~~~~~~~~~v~is~D~d~~~~~~~~~~~~~~~~~~~~~~~ 284 (297)
+.+.+++|+|+|+. ++++++++++.|+.++++.++.+. ....+..++...+...|.+|+|
T Consensus 181 ~~g~~~~~~~iGir~~~~~~~~~~~~~~~g~~~~~~~e~~~~--------------g~~~~~~~i~~~l~~~~~vylS-- 244 (314)
T PRK13772 181 ARGQPFDYACLGVSRLSNTPALFARADALGVRYVEDVDMQER--------------HLDARLAELDALLDAADHVYLT-- 244 (314)
T ss_pred hcCCcceEEEEecCCCCCChhHHHHHHhCCeEEEEhhhhhhc--------------CHHHHHHHHHHHHhcCCeEEEE--
Confidence 44568999999996 788899999999999999998653 2223345566666667788888
Q ss_pred ccccccccccc
Q 022416 285 LTFDVFIQTTA 295 (297)
Q Consensus 285 ~~~d~~~~~~~ 295 (297)
||+|||-.+.|
T Consensus 245 ~DiD~lDps~a 255 (314)
T PRK13772 245 IDLDVLPAAVA 255 (314)
T ss_pred EEecCcCcccC
Confidence 88888866543
No 8
>PRK13774 formimidoylglutamase; Provisional
Probab=100.00 E-value=1.4e-39 Score=305.85 Aligned_cols=202 Identities=17% Similarity=0.184 Sum_probs=166.2
Q ss_pred cCcEEEEEeecCCCC---CCCCCccchHHHHHHHHhcCCCCCCcccCCCCCCCccccccCCcccccccCCCCCHHHHHHH
Q 022416 59 VASTSLLGVPLGHNS---SFLQGPAFAPPRIREAIWCGSTNSTTEEGKELNDPRVLTDVGDVPVQEIRDCGVDDDRLMNV 135 (297)
Q Consensus 59 ~~~i~llGvP~D~g~---s~r~Ga~~GP~aIR~a~~~~~~~~~~~~g~~~~~~~~i~D~GDv~~~~~~~~~~~~~~~~~~ 135 (297)
+++++|||+|+|.|+ ++|+|+++||++||+++.++... .+...++|+|||.+.. .+.++++++
T Consensus 43 ~~~v~iiGvP~d~g~~~n~~r~G~~~gP~aIR~as~~l~~~---------~~~~~i~D~Gdv~~~~-----~~~~~~~~~ 108 (311)
T PRK13774 43 PSGVGILGYAVDKGVALNKGRIGAKEGPDAIKQAFAGLPDL---------NQCETLVDYGNVYHDH-----EELIDTQKE 108 (311)
T ss_pred CCCEEEEEecccccccCCCCCcCHhHhHHHHHHHhhcCCcc---------cccCeEEECCCCCCCc-----cHHHHHHHH
Confidence 458999999999998 78999999999999998754311 1111589999998653 357899999
Q ss_pred HHHHHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHcC-CCeEEEEEecCCCCCCCCCCCccCCchHHHHHHcCCCCCcE
Q 022416 136 ITESVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKLG-GPVDVLHLDAHPDIYDAFEGNKYSHASSFARIMEGGYARRL 214 (297)
Q Consensus 136 l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~~-~~i~VI~fDAH~Dl~~~~~G~~~shGt~~~~~~e~g~~~~i 214 (297)
+++.+.++++++ .+||+||||||+|+|+++|++++++ ++++|||||||+|+|+++. .+||++|+++++++..+++
T Consensus 109 i~~~v~~i~~~g-~~pivlGGdHsit~g~~~a~~~~~~~~~igvI~~DAH~Dlr~~~~---~~~g~~~~~i~e~~~~~~~ 184 (311)
T PRK13774 109 FAMLAAKSIANH-RQTFLLGGGHDIAYAQYLATRKVYPTQSIGVINIDAHFDTRAEQQ---STSGTSFRQILEEDENTDY 184 (311)
T ss_pred HHHHHHHHHHCC-CeEEEEcCchHHHHHHHHHHHhhcCCCceEEEEeCCCCCCCCCCC---CCCChHHHHHHhcCCCCCE
Confidence 999999999998 6999999999999999999999874 3699999999999999864 4799999999987656899
Q ss_pred EEEeeCCC--CHHHHHHHHHcCCeEEEcccccccccccccceEEEEecchhccchhhhHHHHhhchhhcccccccccccc
Q 022416 215 LQVGIRSI--TKEGREQGKRFGVEQYEMRTFSRDRQFLENLVSLSLLLKYIHILSQLQTVIRAYIAFFYLLCLTFDVFIQ 292 (297)
Q Consensus 215 v~iGiR~~--~~~e~~~~~~~gv~~~~~~di~~~~~~~~~~v~is~D~d~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 292 (297)
+|+|+|+. .++++++++++|+.+++++++++. ....+...++.+++..|.+|+| +|+|||-.
T Consensus 185 ~~iGir~~~~~~~~~~~~~~~g~~~~~~~~i~~~--------------~~~~~~~~l~~~~~~~~~vyvS--~DiD~lDp 248 (311)
T PRK13774 185 LVLGIAQGGNTQSLFDYAKEKKIDYVFADELLSH--------------VSPTIKDMIERFIHEHDVIMFT--ICMDVIDS 248 (311)
T ss_pred EEEeeCCCCCCHHHHHHHHHcCCEEEEHHHhhhh--------------hHHHHHHHHHHHHhcCCeEEEE--EeeCCcCh
Confidence 99999986 578899999999999999999763 1112344555555556788888 88888854
Q ss_pred cc
Q 022416 293 TT 294 (297)
Q Consensus 293 ~~ 294 (297)
+.
T Consensus 249 s~ 250 (311)
T PRK13774 249 AF 250 (311)
T ss_pred hh
Confidence 43
No 9
>PRK02190 agmatinase; Provisional
Probab=100.00 E-value=1.8e-39 Score=303.76 Aligned_cols=215 Identities=22% Similarity=0.347 Sum_probs=167.3
Q ss_pred ccccccchhhhhhhhhhhhHHHhhhcCCcCcEEEEEeecCCCCCCCCCccchHHHHHHHHhcCCC-CCCcccCCCCCCCc
Q 022416 31 NRVIDASLTLIRERAKLKGELVRALGGAVASTSLLGVPLGHNSSFLQGPAFAPPRIREAIWCGST-NSTTEEGKELNDPR 109 (297)
Q Consensus 31 ~~~~~~~~tf~~~~~~~~~~~~~~l~~~~~~i~llGvP~D~g~s~r~Ga~~GP~aIR~a~~~~~~-~~~~~~g~~~~~~~ 109 (297)
..+++++.||++.|+.. .++++ .++++|+|+|+|.|+++|+|+++||++||+++..+.+ ......+.+..+..
T Consensus 4 ~~~~~~~~~f~~~~~~~----~~~~~--~~~v~iiGvP~d~g~~~~~G~~~gP~aiR~as~~~~~~~~~~~~~~~~~~~~ 77 (301)
T PRK02190 4 ESLYSNAFSFLRRPLNF----TPYLS--GADWVVTGVPFDMATSGRPGARFGPAAIRQASTNLAWEDRRYPWNFDLFERL 77 (301)
T ss_pred CCcCCCCcccccCCccC----CCccC--CCCEEEEecccCCCCCCCCchhhhHHHHHHHHhcccccccCCCcccCcccCc
Confidence 34567777898886411 13333 4599999999999999999999999999999987542 11111122222335
Q ss_pred cccccCCcccccccCCCCCHHHHHHHHHHHHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHcCCCeEEEEEecCCCCCC
Q 022416 110 VLTDVGDVPVQEIRDCGVDDDRLMNVITESVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKLGGPVDVLHLDAHPDIYD 189 (297)
Q Consensus 110 ~i~D~GDv~~~~~~~~~~~~~~~~~~l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~~~~i~VI~fDAH~Dl~~ 189 (297)
.++|+||+++.. .+.+++++++++.++++++++ .+||+||||||+|+|+++|+.+++ ++++|||||||+|+++
T Consensus 78 ~i~D~Gdv~~~~-----~~~~~~~~~i~~~v~~~~~~g-~~pi~lGGdHsit~~~~~a~~~~~-~~~~vi~~DAH~D~~~ 150 (301)
T PRK02190 78 AVVDYGDLVFDY-----GDAEDFPEALEAHAEKILAAG-KRMLTLGGDHFITLPLLRAHAKHF-GPLALVHFDAHTDTWA 150 (301)
T ss_pred eEEecCCCcCCC-----CCHHHHHHHHHHHHHHHHhCC-CeEEEECCcchhhHHHHHHHHHHc-CCeEEEEEecCCCCCC
Confidence 689999998754 357899999999999999998 599999999999999999999987 4999999999999999
Q ss_pred CCCCCccCCchHHHHHHcCCC--CCcEEEEeeCCCCHHHHHHHHHcCCeEEEcccccccc----------cccccceEEE
Q 022416 190 AFEGNKYSHASSFARIMEGGY--ARRLLQVGIRSITKEGREQGKRFGVEQYEMRTFSRDR----------QFLENLVSLS 257 (297)
Q Consensus 190 ~~~G~~~shGt~~~~~~e~g~--~~~iv~iGiR~~~~~e~~~~~~~gv~~~~~~di~~~~----------~~~~~~v~is 257 (297)
++. +.++|||||+++++++. +++++|||+|+ ++.++.|+.++++.++++.. .....++|||
T Consensus 151 ~~~-~~~~hg~~~~~~~~~~~v~~~~vv~iGiR~------~~~~~~gi~~~~~~~~~~~g~~~~~~~~~~~l~~~~vyiS 223 (301)
T PRK02190 151 DGG-SRIDHGTMFYHAPKEGLIDPAHSVQIGIRT------EYDKDNGFTVLDARQVNDRGVDAIIAQIKQIVGDMPVYLT 223 (301)
T ss_pred Ccc-CCCCCchHHHHHhcCCCcCCCcEEEEECCC------chHHHCCCEEEEHHHhhccCHHHHHHHHHHHhCCCEEEEE
Confidence 875 66899999999998764 58999999998 34578899999999886531 1122456666
Q ss_pred Eecchhcc
Q 022416 258 LLLKYIHI 265 (297)
Q Consensus 258 ~D~d~~~~ 265 (297)
+|+|++++
T Consensus 224 iDiDvlDp 231 (301)
T PRK02190 224 FDIDCLDP 231 (301)
T ss_pred EeecccCc
Confidence 66666664
No 10
>PRK01722 formimidoylglutamase; Provisional
Probab=100.00 E-value=2.1e-39 Score=305.66 Aligned_cols=200 Identities=24% Similarity=0.396 Sum_probs=165.3
Q ss_pred cCcEEEEEeecCCCC---CCCCCccchHHHHHHHHhcCCCCCCcccCCCCCCCccccccCCcccccccCCCCCHHHHHHH
Q 022416 59 VASTSLLGVPLGHNS---SFLQGPAFAPPRIREAIWCGSTNSTTEEGKELNDPRVLTDVGDVPVQEIRDCGVDDDRLMNV 135 (297)
Q Consensus 59 ~~~i~llGvP~D~g~---s~r~Ga~~GP~aIR~a~~~~~~~~~~~~g~~~~~~~~i~D~GDv~~~~~~~~~~~~~~~~~~ 135 (297)
.++++|||+|+|.|+ ++|+|+++||++||+++..+..+. . + ..++|+||+++.. .+.++++++
T Consensus 40 ~~~i~iiG~P~d~g~~~n~~r~Ga~~gP~aiR~a~~~~~~~~----~----~-~~i~D~Gdv~~~~-----~~~~~~~~~ 105 (320)
T PRK01722 40 EEGIALLGFACDEGVPRNKGRSGASFAPDAIRRALANMASHA----G----H-ERLYDLGDITCHV-----TDLEEAQQA 105 (320)
T ss_pred CCCEEEEccccccCcCCCCCCccHHHhHHHHHHHHHhccccC----C----C-CeEEECCCcCcCc-----hhHHHHHHH
Confidence 468999999999998 589999999999999987754321 0 1 2389999998754 357999999
Q ss_pred HHHHHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHc-CCCeEEEEEecCCCCCCCCCCCccCCchHHHHHHcC--C--C
Q 022416 136 ITESVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKL-GGPVDVLHLDAHPDIYDAFEGNKYSHASSFARIMEG--G--Y 210 (297)
Q Consensus 136 l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~-~~~i~VI~fDAH~Dl~~~~~G~~~shGt~~~~~~e~--g--~ 210 (297)
+++.+.++++++ .+||+||||||+|+|+++|+.+++ .++++|||||||+|+++++.| .++|||||+++++. + .
T Consensus 106 i~~~v~~~~~~g-~~pi~lGGdHsit~~~~~al~~~~~~~~i~vI~~DAH~Dl~~~~~~-~~~hg~~~~~l~~~~~~~~~ 183 (320)
T PRK01722 106 LADTVGHCLRPN-MRTIVLGGGHEIAFGSFAGVADAFPKGKVGIINFDAHHDLRNLEDG-GPSSGTPFRQLLEYCDAQIR 183 (320)
T ss_pred HHHHHHHHHhCC-CeeEEEcCchHHHHHHHHHHHhhccCCcEEEEEEecCccCCCCCCC-CCCCChHHHHHhhhhhccCC
Confidence 999999999998 699999999999999999999832 268999999999999998766 78999999999983 2 3
Q ss_pred CCcEEEEeeCCC--CHHHHHHHHHcCCeEEEcccccccccccccceEEEEecchhccchhhhHHHHhhchhhcccccccc
Q 022416 211 ARRLLQVGIRSI--TKEGREQGKRFGVEQYEMRTFSRDRQFLENLVSLSLLLKYIHILSQLQTVIRAYIAFFYLLCLTFD 288 (297)
Q Consensus 211 ~~~iv~iGiR~~--~~~e~~~~~~~gv~~~~~~di~~~~~~~~~~v~is~D~d~~~~~~~~~~~~~~~~~~~~~~~~~~d 288 (297)
+++++|||+|++ ++++++++++.|+.++++.++.+. ..-.+..++...|+..|.+|+| ||+|
T Consensus 184 ~~~~~~iGiR~~~~~~~~~~~~~~~g~~~~~~~~i~~~--------------g~~~~~~~~~~~i~~~~~vyvS--~DiD 247 (320)
T PRK01722 184 GFHYACIGVSRASNTQALWEEAKELGVTVVTDLDVRER--------------GLKDILTELQEFIDQVDYIYLT--IDLD 247 (320)
T ss_pred CCCEEEEEecCCCCCHHHHHHHHHCCCEEEEHHHhhhc--------------CHHHHHHHHHHHHhcCCeEEEE--EEec
Confidence 589999999995 578899999999999999998653 2223445555556556778888 8888
Q ss_pred cc
Q 022416 289 VF 290 (297)
Q Consensus 289 ~~ 290 (297)
||
T Consensus 248 vl 249 (320)
T PRK01722 248 VL 249 (320)
T ss_pred Cc
Confidence 87
No 11
>PRK13776 formimidoylglutamase; Provisional
Probab=100.00 E-value=3.1e-39 Score=304.26 Aligned_cols=202 Identities=22% Similarity=0.331 Sum_probs=168.9
Q ss_pred cCcEEEEEeecCCCC---CCCCCccchHHHHHHHHhcCCCCCCcccCCCCCCCccccccCCcccccccCCCCCHHHHHHH
Q 022416 59 VASTSLLGVPLGHNS---SFLQGPAFAPPRIREAIWCGSTNSTTEEGKELNDPRVLTDVGDVPVQEIRDCGVDDDRLMNV 135 (297)
Q Consensus 59 ~~~i~llGvP~D~g~---s~r~Ga~~GP~aIR~a~~~~~~~~~~~~g~~~~~~~~i~D~GDv~~~~~~~~~~~~~~~~~~ 135 (297)
.++++|||+|+|.|+ ++|+|+++||++||+++..+.++. + ..++|+|||++.. .+.++++++
T Consensus 41 ~~~v~iiGvP~d~g~~~n~~r~G~r~gP~aiR~a~~~~~~~~----~------~~i~D~Gdv~~~~-----~~~~~~~~~ 105 (318)
T PRK13776 41 EPKVALLGFACDAGVRRNQGRVGAKHGPDAIRRALANLPWHG----G------RAVVDAGDVVCED-----DDLEAAQSR 105 (318)
T ss_pred CCCEEEEeeccccccCCCCCCcChhHCHHHHHHHhhcccccC----C------CeEEECCCCCCCc-----chHHHHHHH
Confidence 459999999999998 799999999999999987654221 1 3489999998764 357999999
Q ss_pred HHHHHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHcC-----CCeEEEEEecCCCCCCCCCCCccCCchHHHHHHcC--
Q 022416 136 ITESVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKLG-----GPVDVLHLDAHPDIYDAFEGNKYSHASSFARIMEG-- 208 (297)
Q Consensus 136 l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~~-----~~i~VI~fDAH~Dl~~~~~G~~~shGt~~~~~~e~-- 208 (297)
+++.++++++++ ++||+||||||+|+|+++|+.++++ ++++|||||||+|++++ +.++|||||++++|+
T Consensus 106 i~~~v~~i~~~g-~~Pi~lGGdHsit~g~~~a~~~~~~~~~~~~~vgvI~~DAH~D~~~~---~~~~~g~~~r~~~e~~~ 181 (318)
T PRK13776 106 YAQRVHDLLDRG-HLPIGLGGGHEIAWASFQGLARHLARSAPLPRIGIINFDAHFDLRKG---ERGSSGTPFRQIAEYCA 181 (318)
T ss_pred HHHHHHHHHhCC-CeEEEEcCchHHHHHhHHHHHHHhhcccCCCceEEEEeCCcccCCCC---CCCCCCCHHHHHHHHHh
Confidence 999999999999 6999999999999999999999861 48999999999999954 347899999999973
Q ss_pred --CCCCcEEEEeeCCC--CHHHHHHHHHcCCeEEEcccccccccccccceEEEEecchhccchhhhHHHHhhchhhcccc
Q 022416 209 --GYARRLLQVGIRSI--TKEGREQGKRFGVEQYEMRTFSRDRQFLENLVSLSLLLKYIHILSQLQTVIRAYIAFFYLLC 284 (297)
Q Consensus 209 --g~~~~iv~iGiR~~--~~~e~~~~~~~gv~~~~~~di~~~~~~~~~~v~is~D~d~~~~~~~~~~~~~~~~~~~~~~~ 284 (297)
+.+.+++|+|+|++ ++++++++++.|+.++++.++++. ..-.+..++..++...|.+|+|
T Consensus 182 ~~g~~~~~~~iGir~~~~~~~~~~~~~~~g~~~~~~~ei~~~--------------g~~~v~~~~~~~~~~~~~vyvS-- 245 (318)
T PRK13776 182 AKGWPFHYCCLGVSRFSNTAALFERAKQLGVRYLSDEDMYEW--------------SLARILAFLDDFIANVDHIYLT-- 245 (318)
T ss_pred hcCCcceEEEEccCCCCCCHHHHHHHHHcCCEEEEHHHhhhc--------------CHHHHHHHHHHHHhcCCeEEEE--
Confidence 44678999999997 578899999999999999999764 2223445666677777888888
Q ss_pred ccccccccccc
Q 022416 285 LTFDVFIQTTA 295 (297)
Q Consensus 285 ~~~d~~~~~~~ 295 (297)
+|+|||-.+.|
T Consensus 246 ~DiD~lDps~a 256 (318)
T PRK13776 246 ICLDVLPAAVA 256 (318)
T ss_pred EEeCCcCcccC
Confidence 88888866543
No 12
>PRK13773 formimidoylglutamase; Provisional
Probab=100.00 E-value=3.6e-39 Score=304.50 Aligned_cols=202 Identities=22% Similarity=0.261 Sum_probs=169.0
Q ss_pred cCcEEEEEeecCCCC---CCCCCccchHHHHHHHHhcCCCCCCcccCCCCCCCccccccCCcccccccCCCCCHHHHHHH
Q 022416 59 VASTSLLGVPLGHNS---SFLQGPAFAPPRIREAIWCGSTNSTTEEGKELNDPRVLTDVGDVPVQEIRDCGVDDDRLMNV 135 (297)
Q Consensus 59 ~~~i~llGvP~D~g~---s~r~Ga~~GP~aIR~a~~~~~~~~~~~~g~~~~~~~~i~D~GDv~~~~~~~~~~~~~~~~~~ 135 (297)
+++++|||+|||.|+ ++|+|+++||++||+++..+... .+ ..++|+|||.+.. .+.++++++
T Consensus 43 ~~~i~iiGvP~d~g~~~n~~r~G~~~gP~aIR~a~~~~~~~----~~------~~i~D~Gdv~~~~-----~~~~~~~~~ 107 (324)
T PRK13773 43 ARGCVLLGFASDEGVRRNKGRVGAAAGPDALRGALGSLALH----EP------RRVYDAGTVTVPG-----GDLEAGQER 107 (324)
T ss_pred CCCEEEEEeccccCCCCCCCCCChhHCHHHHHHHHhhchhc----cC------CeEEeCCCcCCCC-----cCHHHHHHH
Confidence 468999999999998 78999999999999998765421 12 3489999998754 357899999
Q ss_pred HHHHHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHc----CCCeEEEEEecCCCCCCCCCCCccCCchHHHHHHcC---
Q 022416 136 ITESVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKL----GGPVDVLHLDAHPDIYDAFEGNKYSHASSFARIMEG--- 208 (297)
Q Consensus 136 l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~----~~~i~VI~fDAH~Dl~~~~~G~~~shGt~~~~~~e~--- 208 (297)
++++|+++++++ ++||+||||||+|+|+++|+.+++ +++++|||||||+|++++. .++|||||++++++
T Consensus 108 i~~~v~~~~~~g-~~PivLGGdHsit~g~~~a~~~~~~~~~~~~vgvI~~DAH~D~~~~~---~~~~G~p~~~~~~~~~~ 183 (324)
T PRK13773 108 LGDAVSALLDAG-HLPVVLGGGHETAFGSYLGVAGSERRRPGKRLGILNLDAHFDLRAAP---VPSSGTPFRQIARAEEA 183 (324)
T ss_pred HHHHHHHHHHCC-CeeEEECCchHHHHHhHHHHHHhhhcccCCceEEEEeCCCccCCCCC---CCCCChHHHHHhhcccc
Confidence 999999999998 699999999999999999999986 2489999999999999873 37899999999984
Q ss_pred -CCCCcEEEEeeCCC--CHHHHHHHHHcCCeEEEcccccccccccccceEEEEecchhccchhhhHHHHhhchhhccccc
Q 022416 209 -GYARRLLQVGIRSI--TKEGREQGKRFGVEQYEMRTFSRDRQFLENLVSLSLLLKYIHILSQLQTVIRAYIAFFYLLCL 285 (297)
Q Consensus 209 -g~~~~iv~iGiR~~--~~~e~~~~~~~gv~~~~~~di~~~~~~~~~~v~is~D~d~~~~~~~~~~~~~~~~~~~~~~~~ 285 (297)
+...+++++|+|+. +++++++++++|+.++++++++.. +...+...+..+|+..|.+|+| |
T Consensus 184 ~~~~~~~~~iGir~~~~~~~~~~~~~~~g~~~~~~~~i~~~--------------~~~~~~~~~~~~l~~~~~vylS--~ 247 (324)
T PRK13773 184 AGRTFQYSVLGISEPNNTRALFDTARELGVRYLLDEECQVM--------------DRAAVRVFVADFLADVDVIYLT--I 247 (324)
T ss_pred cCCCccEEEeecCcccccHHHHHHHHHcCCEEEEHHHhhhc--------------CHHHHHHHHHHHHhcCCeEEEE--E
Confidence 33478999999985 678899999999999999999664 2334556666777777888988 8
Q ss_pred cccccccccc
Q 022416 286 TFDVFIQTTA 295 (297)
Q Consensus 286 ~~d~~~~~~~ 295 (297)
|+|||-.+.|
T Consensus 248 DiD~lDps~a 257 (324)
T PRK13773 248 DLDVLPAAVA 257 (324)
T ss_pred eeCcCCcccC
Confidence 8888876654
No 13
>PF00491 Arginase: Arginase family; InterPro: IPR006035 The ureohydrolase superfamily includes arginase (3.5.3.1 from EC), agmatinase (3.5.3.11 from EC), formiminoglutamase (3.5.3.8 from EC) and proclavaminate amidinohydrolase (3.5.3.22 from EC) []. These enzymes share a 3-layer alpha-beta-alpha structure [, , ], and play important roles in arginine/agmatine metabolism, the urea cycle, histidine degradation, and other pathways. Arginase, which catalyses the conversion of arginine to urea and ornithine, is one of the five members of the urea cycle enzymes that convert ammonia to urea as the principal product of nitrogen excretion []. There are several arginase isozymes that differ in catalytic, molecular and immunological properties. Deficiency in the liver isozyme leads to argininemia, which is usually associated with hyperammonemia. Agmatinase hydrolyses agmatine to putrescine, the precursor for the biosynthesis of higher polyamines, spermidine and spermine. In addition, agmatine may play an important regulatory role in mammals. Formiminoglutamase catalyses the fourth step in histidine degradation, acting to hydrolyse N-formimidoyl-L-glutamate to L-glutamate and formamide. Proclavaminate amidinohydrolase is involved in clavulanic acid biosynthesis. Clavulanic acid acts as an inhibitor of a wide range of beta-lactamase enzymes that are used by various microorganisms to resist beta-lactam antibiotics. As a result, this enzyme improves the effectiveness of beta-lactamase antibiotics [].; GO: 0016813 hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines, 0046872 metal ion binding; PDB: 4DZ4_A 3SL0_A 3MMR_A 3SL1_A 2EF5_D 2EIV_K 2EF4_A 3NIO_F 3THH_A 1WVA_A ....
Probab=100.00 E-value=6.5e-39 Score=296.08 Aligned_cols=178 Identities=35% Similarity=0.585 Sum_probs=145.0
Q ss_pred CcEEEEEeecCCCCCCCCCccchHHHHHHHHhcCCCCCCcccCCCCCCCccccccCCcccccccCCCCCHHHHHHHHHHH
Q 022416 60 ASTSLLGVPLGHNSSFLQGPAFAPPRIREAIWCGSTNSTTEEGKELNDPRVLTDVGDVPVQEIRDCGVDDDRLMNVITES 139 (297)
Q Consensus 60 ~~i~llGvP~D~g~s~r~Ga~~GP~aIR~a~~~~~~~~~~~~g~~~~~~~~i~D~GDv~~~~~~~~~~~~~~~~~~l~~~ 139 (297)
++++|||+|+|.+.++++|+++||++||+++..+.. .. +...+......++|+||+.... +.++++++++++
T Consensus 1 a~i~iiGvP~d~~~~~~~G~~~gP~air~a~~~~~~-~~-~~~~~~~~~~~i~D~Gdv~~~~------~~~~~~~~l~~~ 72 (277)
T PF00491_consen 1 ADIVIIGVPYDGTGSGRPGARFGPDAIREASYRLSP-QL-EYDLDLGEQLSIVDLGDVPVPP------DNEQVFERLAEA 72 (277)
T ss_dssp ESEEEEEEE--TTTSSSTTGGGHHHHHHHHHCTSHS-CH-HEETCTTGTSEEEEEEEEE-SS------SHHHHHHHHHHH
T ss_pred CeEEEEEeecCCCCCCCCCHHHHHHHHHHHHhhccc-cc-CCCccccccceEEEcCCCcCCc------cHHHHHHHHHHH
Confidence 489999999999888999999999999999876553 10 0011111235689999997763 346689999999
Q ss_pred HHHHHhcCCceeEEeCCCCcchHHhHHHHHHHcCCCeEEEEEecCCCCCCCC-CCCccCCchHHHHHHcCCC--CCcEEE
Q 022416 140 VKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKLGGPVDVLHLDAHPDIYDAF-EGNKYSHASSFARIMEGGY--ARRLLQ 216 (297)
Q Consensus 140 v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~~~~i~VI~fDAH~Dl~~~~-~G~~~shGt~~~~~~e~g~--~~~iv~ 216 (297)
++++++++ .+||+||||||+|+|.++|+.+.++++++|||||||+|+++++ +++.++|||||+++++++. ++++++
T Consensus 73 v~~~~~~g-~~pi~lGGdhsis~~~~~~l~~~~~~~i~vI~~DAH~D~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~v~ 151 (277)
T PF00491_consen 73 VAEVLEAG-AFPIVLGGDHSISYGTIAALARAYGGPIGVIWFDAHPDLRTPETSGSGNSHGMPLRRALEEPLLDPENVVQ 151 (277)
T ss_dssp HHHHHHTT-EEEEEEESSGGGHHHHHHHHHHHHTTTEEEEEESSS----STTTTTSSSGTTSHHHHHHHTTSSEGGGEEE
T ss_pred HHHhhcCC-CEEEecCCCchhHHHhHHHHHhhcCCCeeEEEecCccCCCcccccCCCCCCCChhhhhcccCCcCcCcEEE
Confidence 99999998 6999999999999999999999987799999999999999998 7788999999999997754 389999
Q ss_pred EeeCCCCHH-HHHHHHHcCCeEEEccccccc
Q 022416 217 VGIRSITKE-GREQGKRFGVEQYEMRTFSRD 246 (297)
Q Consensus 217 iGiR~~~~~-e~~~~~~~gv~~~~~~di~~~ 246 (297)
||+|+...+ |++++++.|+.+++++++++.
T Consensus 152 iG~r~~~~~~e~~~~~~~~i~~~~~~~i~~~ 182 (277)
T PF00491_consen 152 IGIRSFDNESEYEYLKELGIKIFSADEIRED 182 (277)
T ss_dssp EEE-STTHHHHHHHHHHTTSEEEEHHHHHHH
T ss_pred EecccccchHHHHHHHHcCCEEEehhHhhhh
Confidence 999999888 999999999999999999864
No 14
>TIGR01229 rocF_arginase arginase. This model helps resolve arginases from known and putative agmatinases, formiminoglutamases, and other related proteins of unknown specifity. The pathway from arginine to the polyamine putrescine may procede by hydrolysis to remove urea (arginase) followed by decarboxylation (ornithine decarboxylase), or by decarboxylation first (arginine decarboxylase) followed by removal of urea (agmatinase).
Probab=100.00 E-value=8.4e-38 Score=292.38 Aligned_cols=205 Identities=24% Similarity=0.290 Sum_probs=159.2
Q ss_pred EEEEeecCCCCCCCCCccchHHHHHHHH-hcCCCCCCcccCCCCCCCccccccCCcccccccC--------CCCCHHHHH
Q 022416 63 SLLGVPLGHNSSFLQGPAFAPPRIREAI-WCGSTNSTTEEGKELNDPRVLTDVGDVPVQEIRD--------CGVDDDRLM 133 (297)
Q Consensus 63 ~llGvP~D~g~s~r~Ga~~GP~aIR~a~-~~~~~~~~~~~g~~~~~~~~i~D~GDv~~~~~~~--------~~~~~~~~~ 133 (297)
.|||+|+|.|++ |+|+++||++||+++ ..... ..+ ..+.|+||+.+....+ ...+.++++
T Consensus 1 ~liG~P~d~G~~-~~Ga~~gP~aiR~a~l~~~~~----~~~------~~i~D~Gdv~~~~~~~~~~~~~~~~~~~~~~~~ 69 (300)
T TIGR01229 1 GIVGLPFSLGQP-RRGVDKGPSRLREAGLLETLR----ELE------YDMQDLGQLPFAVRPKESPRYAVKNPRYVLAAT 69 (300)
T ss_pred CEEEEecCCCCC-CccHHHhHHHHHHcChHHHHH----hcC------CeeEECCccccCccccccccccccCHHHHHHHH
Confidence 489999999974 899999999999994 32110 112 2479999998532100 012568889
Q ss_pred HHHHHHHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHcC-CCeEEEEEecCCCCCCCCC-CCccCCchHHHHHHcCC--
Q 022416 134 NVITESVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKLG-GPVDVLHLDAHPDIYDAFE-GNKYSHASSFARIMEGG-- 209 (297)
Q Consensus 134 ~~l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~~-~~i~VI~fDAH~Dl~~~~~-G~~~shGt~~~~~~e~g-- 209 (297)
+++++.++++++++ .+||+||||||+|+|+++|++++++ ++++|||||||+|+++++. ++.++|||||+++++.+
T Consensus 70 ~~i~~~v~~~~~~g-~~pi~lGGdHsi~~~~~~a~~~~~~~~~~gvI~~DAH~D~~~~~~~~s~~~hG~p~~~~~~~~~~ 148 (300)
T TIGR01229 70 EQLAPKVYEVFEEG-RFPLVLGGDHSIAIGTISGTARVHPDKKLGVLWLDAHADINTPETTTSGNLHGMPVAFLLGRLKS 148 (300)
T ss_pred HHHHHHHHHHHhCC-CeeEEEcCcchhhhhhHHHHHHhcCCCceEEEEEecCcccCCCCCCCCCCcccCHHHHHhcccCc
Confidence 99999999999999 5999999999999999999999874 2599999999999999864 56788999999998621
Q ss_pred ---------------CCCcEEEEeeCCCCHHHHHHHHHcCCeEEEcccccccccccccceEEEEecchhccchhhhHHHH
Q 022416 210 ---------------YARRLLQVGIRSITKEGREQGKRFGVEQYEMRTFSRDRQFLENLVSLSLLLKYIHILSQLQTVIR 274 (297)
Q Consensus 210 ---------------~~~~iv~iGiR~~~~~e~~~~~~~gv~~~~~~di~~~~~~~~~~v~is~D~d~~~~~~~~~~~~~ 274 (297)
.+++++|||+|+++++|+++++++|+.++++.++++. ..-.+..++...++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~v~iGiR~~~~~e~~~~~~~gi~~~~~~~i~~~--------------g~~~v~~~~~~~l~ 214 (300)
T TIGR01229 149 EFPDSPGLGWVAPEISPKNLVYIGLRSVDPGERKILKELGIKVFSMHEIDEL--------------GIGKVVEETLEYLK 214 (300)
T ss_pred cccccccccccCCccCcccEEEEecCCCChHHHHHHHHcCCeEEEHHHHhhh--------------hHHHHHHHHHHHHh
Confidence 2469999999999999999999999999999999764 22233444445555
Q ss_pred hhc-hhhccccccccccccccc
Q 022416 275 AYI-AFFYLLCLTFDVFIQTTA 295 (297)
Q Consensus 275 ~~~-~~~~~~~~~~d~~~~~~~ 295 (297)
..| .+|++ +|+|||-.+.|
T Consensus 215 ~~~~~vyvS--~DiDvlDps~a 234 (300)
T TIGR01229 215 AEDGPIHLS--LDVDGLDPSLA 234 (300)
T ss_pred cCCCeEEEE--EeccccCcccC
Confidence 555 67777 77777755443
No 15
>KOG2965 consensus Arginase [Amino acid transport and metabolism]
Probab=99.97 E-value=4.4e-31 Score=236.25 Aligned_cols=192 Identities=23% Similarity=0.305 Sum_probs=157.8
Q ss_pred cEEEEEeecCCCCCCCCCccchHHHHHHHHhcCCCCCCcccCCCCCCCccccccCCccccccc-C---------CCCCHH
Q 022416 61 STSLLGVPLGHNSSFLQGPAFAPPRIREAIWCGSTNSTTEEGKELNDPRVLTDVGDVPVQEIR-D---------CGVDDD 130 (297)
Q Consensus 61 ~i~llGvP~D~g~s~r~Ga~~GP~aIR~a~~~~~~~~~~~~g~~~~~~~~i~D~GDv~~~~~~-~---------~~~~~~ 130 (297)
.|.+||+||..|+. +.|++.||+.||++.+.-.. .+.| ..+.|.||+.+.... + .+..+.
T Consensus 16 ~v~iIg~pfs~gq~-k~G~E~~pe~i~~agl~~~l---e~lg------~~~~~~g~~~f~~~p~kd~~~~~~~knp~~V~ 85 (318)
T KOG2965|consen 16 VVSIIGAPFSGGQP-KLGVELAPEVIRKAGLLEDL---EDLG------CSVKDWGDLIFKSRPGKDSPNQALAKNPRSVG 85 (318)
T ss_pred heeEeeccccCCCC-ccchhhhHHHHHHhchhhhH---HHcC------CCHHHhcCcccccCCCCCCcchhhhcCchhHh
Confidence 58999999999987 99999999999999754221 0123 124566776553322 0 112456
Q ss_pred HHHHHHHHHHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHcCCCeEEEEEecCCCCCCCC---CCCccCCchHHHHHHc
Q 022416 131 RLMNVITESVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKLGGPVDVLHLDAHPDIYDAF---EGNKYSHASSFARIME 207 (297)
Q Consensus 131 ~~~~~l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~~~~i~VI~fDAH~Dl~~~~---~G~~~shGt~~~~~~e 207 (297)
.+.++++..|+++++++ ..+++||||||+++|++.|++++++ +++|||+|||.|+++|. +||. ||||+..+++
T Consensus 86 ~atrqla~~v~~vve~~-r~~l~lGGDHSlAIGTvsgva~~~~-D~gvlWvDAHaDinTp~ts~SgNL--HG~PvSflLg 161 (318)
T KOG2965|consen 86 NATRQLANEVSQVVENG-RILLVLGGDHSLAIGTVSGVARVYP-DAGVLWVDAHADINTPDTSPSGNL--HGCPVSFLLG 161 (318)
T ss_pred HHHHHHHHHHHHHHhcC-eEEEEecCcceEEEeeehhhHhhCC-CccEEEEecccccCCCCCCCCCCc--CCCcHHHHHh
Confidence 78999999999999988 5899999999999999999999995 99999999999999984 5665 9999999998
Q ss_pred CCC--------------CCcEEEEeeCCCCHHHHHHHHHcCCeEEEcccccccc-------------cccccceEEEEec
Q 022416 208 GGY--------------ARRLLQVGIRSITKEGREQGKRFGVEQYEMRTFSRDR-------------QFLENLVSLSLLL 260 (297)
Q Consensus 208 ~g~--------------~~~iv~iGiR~~~~~e~~~~~~~gv~~~~~~di~~~~-------------~~~~~~v~is~D~ 260 (297)
++. +.++++||+|++++.|..+++++||.+|+|+++++-+ +.-+.|..+|+|+
T Consensus 162 ~~~p~~~~f~w~~p~i~~~~l~yIGLRDvdp~E~~iLk~lgI~~fsm~~Vdk~GI~~Vme~a~~~v~~~~~rpihlSfDv 241 (318)
T KOG2965|consen 162 ELKPLPEGFSWVKPCISPKRLAYIGLRDVDPGEHAILKELGIAAFSMHEVDKYGIQKVMEMAMELVNPGTRRPIHLSFDV 241 (318)
T ss_pred ccCCCCccccccccccChhheEEEecccCChHHHHHHHhcCcceEeehhhHhhhHHHHHHHHHHHhcCCCccceeEEEec
Confidence 642 4799999999999999999999999999999999853 2345799999999
Q ss_pred chhccc
Q 022416 261 KYIHIL 266 (297)
Q Consensus 261 d~~~~~ 266 (297)
|-.++.
T Consensus 242 Dg~Dp~ 247 (318)
T KOG2965|consen 242 DGFDPS 247 (318)
T ss_pred CCcCcc
Confidence 988774
No 16
>PF12640 UPF0489: UPF0489 domain; InterPro: IPR024131 This entry describes a family of uncharacterised proteins found in metazoa.
Probab=94.55 E-value=0.16 Score=43.21 Aligned_cols=35 Identities=34% Similarity=0.680 Sum_probs=22.1
Q ss_pred CCcchHHhH-HHHHHHc-CCCeEEEEEecCCCCCCCC
Q 022416 157 DHSISFPVI-RAVSEKL-GGPVDVLHLDAHPDIYDAF 191 (297)
Q Consensus 157 DHsit~~~i-~al~~~~-~~~i~VI~fDAH~Dl~~~~ 191 (297)
||--++..+ +++.+.. +.+..+||||+|+|+..|.
T Consensus 6 ~H~~al~~w~~~~~~~~l~~~~~lvHiD~H~Dl~~p~ 42 (162)
T PF12640_consen 6 DHNEALPFWYRAIGRGKLPSPNSLVHIDSHPDLRIPF 42 (162)
T ss_pred ChHHHHHHHHHHHhcCCCCCCCeEEEEeCCCCCCccc
Confidence 344444443 3443321 2578999999999998763
No 17
>KOG1384 consensus tRNA delta(2)-isopentenylpyrophosphate transferase [Translation, ribosomal structure and biogenesis]
Probab=57.42 E-value=20 Score=34.43 Aligned_cols=58 Identities=19% Similarity=0.266 Sum_probs=38.2
Q ss_pred CHHHHHHHHHHHHHHHHhcCCceeEEeCCCCcchHHhHHH--------HHHH-------cCCCeEEEEEecCCC
Q 022416 128 DDDRLMNVITESVKLVMEEDPLHPLVLGGDHSISFPVIRA--------VSEK-------LGGPVDVLHLDAHPD 186 (297)
Q Consensus 128 ~~~~~~~~l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~a--------l~~~-------~~~~i~VI~fDAH~D 186 (297)
+..+.......++..++++| +.||+.||-|+---+.+.. +... .+-+-.+||+||-.-
T Consensus 77 t~~~F~~~a~~aie~I~~rg-k~PIv~GGs~~yi~al~~~~~d~~~dp~~~~~g~~pS~lryd~c~lWlda~~~ 149 (348)
T KOG1384|consen 77 TAGEFEDDASRAIEEIHSRG-KLPIVVGGSNSYLQALLSKRFDPKIDPFSSNTGSIPSELRYDCCFLWLDADQA 149 (348)
T ss_pred cHHHHHHHHHHHHHHHHhCC-CCCEEeCCchhhHHHHhhcCCCcccCcccccCCCCCcccccceEEEEEecchH
Confidence 34445556677888899999 5999999999875555543 0000 001367899998653
No 18
>PF01715 IPPT: IPP transferase; InterPro: IPR002627 tRNA isopentenyltransferases 2.5.1.8 from EC also known as tRNA delta(2)-isopentenylpyrophosphate transferases or IPP transferases. These enzymes modify both cytoplasmic and mitochondrial tRNAs at A(37) to give isopentenyl A(37) [].; GO: 0005524 ATP binding, 0008033 tRNA processing; PDB: 2ZXU_A 3FOZ_A 2ZM5_B 3D3Q_A 3EXA_B 2QGN_A 3A8T_A 3EPK_B 3EPH_A 3EPJ_A ....
Probab=37.78 E-value=47 Score=30.40 Aligned_cols=38 Identities=11% Similarity=0.215 Sum_probs=26.5
Q ss_pred CCHHHHHHHHHHHHHHHHhcCCceeEEeCCCCcchHHhH
Q 022416 127 VDDDRLMNVITESVKLVMEEDPLHPLVLGGDHSISFPVI 165 (297)
Q Consensus 127 ~~~~~~~~~l~~~v~~vl~~g~~~pIvLGGDHsit~~~i 165 (297)
.+.....+...+.+.++.++| +.||+.||=+-=--+.+
T Consensus 36 ysv~~f~~~a~~~i~~i~~rg-k~PIlvGGTglYi~all 73 (253)
T PF01715_consen 36 YSVGDFQRDAREAIEDILARG-KIPILVGGTGLYIQALL 73 (253)
T ss_dssp --HHHHHHHHHHHHHHHHHTT--EEEEEES-HHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHhcC-CeEEEECChHHHHHHHH
Confidence 456777888888899999998 59999999654333333
No 19
>TIGR00287 cas1 CRISPR-associated endonuclease Cas1. This model identifies CRISPR-associated protein Cas1, the most universal CRISPR system protein. CRISPR is an acronym for Clustered Regularly Interspaced Short Palindromic Repeats, a system for heritable host defense by prokaryotic cells against phage and other foreign DNA. Cas1 is a metal-dependent DNA-specific endonuclease.
Probab=33.62 E-value=46 Score=31.41 Aligned_cols=34 Identities=29% Similarity=0.432 Sum_probs=28.6
Q ss_pred eEEeCCCCcchHHhHHHHHHHcCCCeEEEEEecCCCC
Q 022416 151 PLVLGGDHSISFPVIRAVSEKLGGPVDVLHLDAHPDI 187 (297)
Q Consensus 151 pIvLGGDHsit~~~i~al~~~~~~~i~VI~fDAH~Dl 187 (297)
-|+++|++++|-++++.+.++ .+.|+++|.+--.
T Consensus 37 ~I~i~g~~~lst~~l~~l~~~---~I~v~f~~~~g~~ 70 (323)
T TIGR00287 37 CIVLFGGVSISSAAIRELAKR---GIDIVFLGGDGNY 70 (323)
T ss_pred EEEEECCCCcCHHHHHHHHHC---CCeEEEECCCCcE
Confidence 456668899999999999985 6999999987653
No 20
>PRK02240 GTP cyclohydrolase III; Provisional
Probab=33.52 E-value=99 Score=28.59 Aligned_cols=52 Identities=12% Similarity=0.006 Sum_probs=33.5
Q ss_pred ccccCCcccccccCCCCCHHHHHHHHHHHHHHHHhcCCceeEEeCCCCcchH
Q 022416 111 LTDVGDVPVQEIRDCGVDDDRLMNVITESVKLVMEEDPLHPLVLGGDHSISF 162 (297)
Q Consensus 111 i~D~GDv~~~~~~~~~~~~~~~~~~l~~~v~~vl~~g~~~pIvLGGDHsit~ 162 (297)
+.++|.-..++.+..+.++...|.++...+.+.+.+-+.+++.+|||+.+++
T Consensus 9 id~YgpWT~t~~prRE~dlQ~lQsrLya~L~~~~~~~ggl~Ff~RgDN~iav 60 (254)
T PRK02240 9 IDNYGPWTVTPNPRRESDLQALQSRLYADLAQQFGARDGYVFFTRFDNMIAV 60 (254)
T ss_pred ecCCCcCcCCCCCccHHHHHHHHHHHHHHHHHHHHhCCCEEEeccCceEEEE
Confidence 4556665555433222345566667766666655543369999999999887
No 21
>PF00491 Arginase: Arginase family; InterPro: IPR006035 The ureohydrolase superfamily includes arginase (3.5.3.1 from EC), agmatinase (3.5.3.11 from EC), formiminoglutamase (3.5.3.8 from EC) and proclavaminate amidinohydrolase (3.5.3.22 from EC) []. These enzymes share a 3-layer alpha-beta-alpha structure [, , ], and play important roles in arginine/agmatine metabolism, the urea cycle, histidine degradation, and other pathways. Arginase, which catalyses the conversion of arginine to urea and ornithine, is one of the five members of the urea cycle enzymes that convert ammonia to urea as the principal product of nitrogen excretion []. There are several arginase isozymes that differ in catalytic, molecular and immunological properties. Deficiency in the liver isozyme leads to argininemia, which is usually associated with hyperammonemia. Agmatinase hydrolyses agmatine to putrescine, the precursor for the biosynthesis of higher polyamines, spermidine and spermine. In addition, agmatine may play an important regulatory role in mammals. Formiminoglutamase catalyses the fourth step in histidine degradation, acting to hydrolyse N-formimidoyl-L-glutamate to L-glutamate and formamide. Proclavaminate amidinohydrolase is involved in clavulanic acid biosynthesis. Clavulanic acid acts as an inhibitor of a wide range of beta-lactamase enzymes that are used by various microorganisms to resist beta-lactam antibiotics. As a result, this enzyme improves the effectiveness of beta-lactamase antibiotics [].; GO: 0016813 hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines, 0046872 metal ion binding; PDB: 4DZ4_A 3SL0_A 3MMR_A 3SL1_A 2EF5_D 2EIV_K 2EF4_A 3NIO_F 3THH_A 1WVA_A ....
Probab=30.94 E-value=31 Score=31.53 Aligned_cols=15 Identities=20% Similarity=0.204 Sum_probs=13.3
Q ss_pred ccceEEEEecchhcc
Q 022416 251 ENLVSLSLLLKYIHI 265 (297)
Q Consensus 251 ~~~v~is~D~d~~~~ 265 (297)
.+++|||+|+|++++
T Consensus 199 ~~~vylsiDiDvlDp 213 (277)
T PF00491_consen 199 TDPVYLSIDIDVLDP 213 (277)
T ss_dssp TSEEEEEEEGGGBBT
T ss_pred CCeEEEEEehhhcCh
Confidence 468999999999985
No 22
>cd06285 PBP1_LacI_like_7 Ligand-binding domain of uncharacterized DNA-binding regulatory proteins that are members of the LacI-GalR family of bacterial transcription repressors. This group includes the ligand-binding domain of uncharacterized DNA-binding regulatory proteins that are members of the LacI-GalR family of bacterial transcription repressors. The LacI-GalR family repressors are composed of two functional domains: an N-terminal HTH (helix-turn-helix) domain, which is responsible for the DNA-binding specificity, and a C-terminal ligand-binding domain, which is homologous to the sugar-binding domain of ABC-type transport systems that contain the type I periplasmic binding protein-like fold. As also observed in the periplasmic binding proteins, the C-terminal domain of the bacterial transcription repressor undergoes a conformational change upon ligand binding which in turn changes the DNA binding affinity of the repressor.
Probab=30.19 E-value=1.1e+02 Score=26.90 Aligned_cols=52 Identities=10% Similarity=0.151 Sum_probs=37.1
Q ss_pred HHHHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHc---CCCeEEEEEecCCCCC
Q 022416 137 TESVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKL---GGPVDVLHLDAHPDIY 188 (297)
Q Consensus 137 ~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~---~~~i~VI~fDAH~Dl~ 188 (297)
.+.+++++++++..-.++..+-.++.+.++++.++- |++++|+=||.-...+
T Consensus 163 ~~~~~~~l~~~~~~~ai~~~~d~~a~g~~~~l~~~g~~~p~di~iig~d~~~~~~ 217 (265)
T cd06285 163 EAAAEKLLRSDSPPTAIFAVNDFAAIGVMGAARDRGLRVPDDVALVGYNDIPLVA 217 (265)
T ss_pred HHHHHHHHcCCCCCCEEEEcCcHHHHHHHHHHHHcCCCCCcceEEEeecCcHHHh
Confidence 345556665543345777778899999999998852 3678999999776543
No 23
>TIGR03638 cas1_ECOLI CRISPR-associated endonuclease Cas1, ECOLI subtype. The CRISPR-associated protein Cas1 is virtually universal to CRISPR systems. CRISPR, an acronym for Clustered Regularly Interspaced Short Palindromic Repeats, is prokaryotic immunity system for foreign DNA, mostly from phage. CRISPR systems belong to different subtypes, distinguished by both nature of the repeats, the makeup of the cohort of associated Cas proteins, and by molecular phylogeny within the more universal Cas proteins such as this one. This model is of type EXCEPTION and provides more specific information than the EQUIVALOG model TIGR00287. It describes the Cas1 protein particular to the ECOLI subtype of CRISPR/Cas system.
Probab=27.03 E-value=74 Score=29.39 Aligned_cols=33 Identities=15% Similarity=0.250 Sum_probs=29.0
Q ss_pred eeEEeCCCCcchHHhHHHHHHHcCCCeEEEEEecCC
Q 022416 150 HPLVLGGDHSISFPVIRAVSEKLGGPVDVLHLDAHP 185 (297)
Q Consensus 150 ~pIvLGGDHsit~~~i~al~~~~~~~i~VI~fDAH~ 185 (297)
--|+++|.-++|-++++.+.++ .+.|+++|..-
T Consensus 46 ~~Ivl~g~~siT~~al~~l~~~---gI~v~~~~~~G 78 (269)
T TIGR03638 46 SCLLLGPGTSVTHAAVKLLARH---GCLVVWVGEGG 78 (269)
T ss_pred cEEEEeCCCccCHHHHHHHHHC---CCEEEEECCCC
Confidence 3688889999999999999995 69999999766
No 24
>TIGR03641 cas1_HMARI CRISPR-associated endonuclease Cas1, HMARI/TNEAP subtype. It describes Cas1 subgroup that includes Cas1 proteins of the related HMARI and TNEAP subtypes of CRISPR/Cas system.
Probab=25.93 E-value=72 Score=30.27 Aligned_cols=33 Identities=12% Similarity=0.140 Sum_probs=28.4
Q ss_pred eEEeCCCCcchHHhHHHHHHHcCCCeEEEEEecCCC
Q 022416 151 PLVLGGDHSISFPVIRAVSEKLGGPVDVLHLDAHPD 186 (297)
Q Consensus 151 pIvLGGDHsit~~~i~al~~~~~~~i~VI~fDAH~D 186 (297)
-|+++|.+++|-++++.+.++ .+.|+++|.+-.
T Consensus 36 ~ivi~g~~~ist~al~~l~~~---gI~v~f~~~~G~ 68 (322)
T TIGR03641 36 EIYVFGEVSLNSKALSFLSKK---GIPIHFFNYYGY 68 (322)
T ss_pred eEEEEcCCccCHHHHHHHHHC---CCeEEEECCCCc
Confidence 467778899999999999985 689999998774
No 25
>COG0324 MiaA tRNA delta(2)-isopentenylpyrophosphate transferase [Translation, ribosomal structure and biogenesis]
Probab=25.90 E-value=88 Score=29.75 Aligned_cols=41 Identities=7% Similarity=0.195 Sum_probs=31.6
Q ss_pred CCHHHHHHHHHHHHHHHHhcCCceeEEeCCCCcchHHhHHHH
Q 022416 127 VDDDRLMNVITESVKLVMEEDPLHPLVLGGDHSISFPVIRAV 168 (297)
Q Consensus 127 ~~~~~~~~~l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al 168 (297)
.+..+.++...+.+.++.++| +.||+.||-+.---+.+.++
T Consensus 72 ysa~~f~~~a~~~i~~i~~rg-k~pIlVGGTglY~~aL~~g~ 112 (308)
T COG0324 72 YSAAEFQRDALAAIDDILARG-KLPILVGGTGLYLKALLEGL 112 (308)
T ss_pred ccHHHHHHHHHHHHHHHHhCC-CCcEEEccHHHHHHHHHcCC
Confidence 466788889999999999999 58999999665544444444
No 26
>PF01867 Cas_Cas1: CRISPR associated protein Cas1; InterPro: IPR002729 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) are a family of DNA direct repeats separated by regularly sized non-repetitive spacer sequences that are found in most bacterial and archaeal genomes []. CRISPRs appear to provide acquired resistance against bacteriophages, possibly acting with an RNA interference-like mechanism to inhibit gene functions of invasive DNA elements [, ]. Differences in the number and type of spacers between CRISPR repeats correlate with phage sensitivity. It is thought that following phage infection, bacteria integrate new spacers derived from phage genomic sequences, and that the removal or addition of particular spacers modifies the phage-resistance phenotype of the cell. Therefore, the specificity of CRISPRs may be determined by spacer-phage sequence similarity. In addition, there are many protein families known as CRISPR-associated sequences (Cas), which are encoded in the vicinity of CRISPR loci []. CRISPR/cas gene regions can be quite large, with up to 20 different, tandem-arranged cas genes next to a CRISPR cluster or filling the region between two repeat clusters. Cas genes and CRISPRs are found on mobile genetic elements such as plasmids, and have undergone extensive horizontal transfer. Cas proteins are thought to be involved in the propagation and functioning of CRISPRs. Some Cas proteins show similarity to helicases and repair proteins, although the functions of most are unknown. Cas families can be divided into subtypes according to operon organisation and phylogeny. This entry represents Cas1, which is a metal-dependent DNA-specific endonuclease []. Cas1 may play a role in the recognition, cleavage, and/or integration of foreign nucleic acids into CRISPRs.; PDB: 2YZS_A 3LFX_D 3PV9_E 3NKE_C 3NKD_A 3GOD_D.
Probab=23.83 E-value=80 Score=29.06 Aligned_cols=33 Identities=33% Similarity=0.422 Sum_probs=26.4
Q ss_pred eEEeCCCCcchHHhHHHHHHHcCCCeEEEEEecCCC
Q 022416 151 PLVLGGDHSISFPVIRAVSEKLGGPVDVLHLDAHPD 186 (297)
Q Consensus 151 pIvLGGDHsit~~~i~al~~~~~~~i~VI~fDAH~D 186 (297)
-|++.|.+++|-++++.+.++ .+.|+++|-+..
T Consensus 37 ~Ivi~g~~~iSt~ai~~l~~~---gI~v~~~~~~G~ 69 (282)
T PF01867_consen 37 SIVIFGGVSISTAAIRLLSKN---GIPVVFLDRRGR 69 (282)
T ss_dssp EEEE-STEEEEHHHHHHHHHT---T-EEEEESTTSE
T ss_pred EEEEcCCCCCCHHHHHHHHHC---CCcEEEeCCCCC
Confidence 466666699999999999985 699999998874
No 27
>TIGR03640 cas1_DVULG CRISPR-associated endonuclease Cas1, DVULG subtype. The CRISPR-associated protein Cas1 is virtually universal to CRISPR systems. CRISPR, an acronym for Clustered Regularly Interspaced Short Palindromic Repeats, is prokaryotic immunity system for foreign DNA, mostly from phage. CRISPR systems belong to different subtypes, distinguished by both nature of the repeats, the makeup of the cohort of associated Cas proteins, and by molecular phylogeny within the more universal Cas proteins such as this one. This model is of type EXCEPTION and provides more specific information than the EQUIVALOG model TIGR00287. It describes the Cas1 protein particular to the DVULG subtype of CRISPR/Cas system.
Probab=22.35 E-value=96 Score=29.61 Aligned_cols=33 Identities=15% Similarity=0.196 Sum_probs=27.5
Q ss_pred eEEeCCCCcchHHhHHHHHHHcCCCeEEEEEecCCC
Q 022416 151 PLVLGGDHSISFPVIRAVSEKLGGPVDVLHLDAHPD 186 (297)
Q Consensus 151 pIvLGGDHsit~~~i~al~~~~~~~i~VI~fDAH~D 186 (297)
-|++.|.+++|-.+++.+.++ .+.|+++|.+--
T Consensus 41 ~Ivi~g~~~ist~al~~l~~~---~I~v~f~~~~G~ 73 (340)
T TIGR03640 41 GIVCFGNVGLSPFLMGRCAED---GISLVFLTENGR 73 (340)
T ss_pred EEEEEcCCCcCHHHHHHHHHC---CCEEEEECCCCe
Confidence 355567899999999999985 699999998874
No 28
>PRK01722 formimidoylglutamase; Provisional
Probab=21.71 E-value=49 Score=31.18 Aligned_cols=14 Identities=14% Similarity=0.287 Sum_probs=12.7
Q ss_pred cceEEEEecchhcc
Q 022416 252 NLVSLSLLLKYIHI 265 (297)
Q Consensus 252 ~~v~is~D~d~~~~ 265 (297)
+++|||+|+|++++
T Consensus 238 ~~vyvS~DiDvlDp 251 (320)
T PRK01722 238 DYIYLTIDLDVLPA 251 (320)
T ss_pred CeEEEEEEecCcCh
Confidence 67999999999977
No 29
>PRK06849 hypothetical protein; Provisional
Probab=20.94 E-value=1.3e+02 Score=28.85 Aligned_cols=35 Identities=14% Similarity=0.142 Sum_probs=29.7
Q ss_pred ceeEEeCCCCcchHHhHHHHHHHcCCCeEEEEEecCCC
Q 022416 149 LHPLVLGGDHSISFPVIRAVSEKLGGPVDVLHLDAHPD 186 (297)
Q Consensus 149 ~~pIvLGGDHsit~~~i~al~~~~~~~i~VI~fDAH~D 186 (297)
.+.+++||++.++++.++++.+. ...|+-+|.+.+
T Consensus 5 ~~VLI~G~~~~~~l~iar~l~~~---G~~Vi~~d~~~~ 39 (389)
T PRK06849 5 KTVLITGARAPAALELARLFHNA---GHTVILADSLKY 39 (389)
T ss_pred CEEEEeCCCcHHHHHHHHHHHHC---CCEEEEEeCCch
Confidence 47999999999999999999986 356888888864
No 30
>cd06281 PBP1_LacI_like_5 Ligand-binding domain of uncharacterized DNA-binding regulatory proteins that are members of the LacI-GalR family of bacterial transcription repressors. This group includes the ligand-binding domain of uncharacterized DNA-binding regulatory proteins that are members of the LacI-GalR family of bacterial transcription repressors. The LacI-GalR family repressors are composed of two functional domains: an N-terminal HTH (helix-turn-helix) domain, which is responsible for the DNA-binding specificity, and a C-terminal ligand-binding domain, which is homologous to the sugar-binding domain of ABC-type transport systems that contain the type I periplasmic binding protein-like fold. As also observed in the periplasmic binding proteins, the C-terminal domain of the bacterial transcription repressor undergoes a conformational change upon ligand binding which in turn changes the DNA binding affinity of the repressor.
Probab=20.12 E-value=2.4e+02 Score=24.66 Aligned_cols=48 Identities=13% Similarity=0.194 Sum_probs=32.8
Q ss_pred HHHHHHHHHHhcCCceeEEeCCCCcchHHhHHHHHHHc---CCCeEEEEEe
Q 022416 135 VITESVKLVMEEDPLHPLVLGGDHSISFPVIRAVSEKL---GGPVDVLHLD 182 (297)
Q Consensus 135 ~l~~~v~~vl~~g~~~pIvLGGDHsit~~~i~al~~~~---~~~i~VI~fD 182 (297)
...+.+.+++++.+..-.++..+.+++.+.++++.++- +++++|+=||
T Consensus 162 ~~~~~~~~~l~~~~~~~ai~~~~d~~a~g~~~~l~~~g~~ip~dv~iig~d 212 (269)
T cd06281 162 SGFDATRALLALPDRPTAIIAGGTQVLVGVLRALREAGLRIPRDLSVISIG 212 (269)
T ss_pred HHHHHHHHHHcCCCCCcEEEEcCcHHHHHHHHHHHHcCCCCCcceeEEEec
Confidence 33455666665443345566777788899999998763 2578888887
Done!